Dr Fortunata Verdetti, MD | |
2128 Blakeslee Boulevard Dr E, Lehighton, PA 18235-9619 | |
(610) 402-5369 | |
Not Available |
Full Name | Dr Fortunata Verdetti |
---|---|
Gender | Female |
Speciality | Hospitalist |
Location | 2128 Blakeslee Boulevard Dr E, Lehighton, Pennsylvania |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386851855 | NPI | - | NPPES |
101954269-0003 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | MD431433 (Pennsylvania) | Secondary |
208M00000X | Hospitalist | MD431433 (Pennsylvania) | Primary |
Entity Name | Lehigh Valley Physician Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
A new study has found evidence that marathon running could trigger pulmonary oedema, where fluid builds up in the lungs.
From the World Science Festival in New York, IBM Fellow Dr. Donald M. Eigler was awarded the most prestigious honor in nanoscience, The Kavli Prize, sharing the honor with Nadrian Seeman, a professor at New York University.
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted applications for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of pancreatic and ovarian cancers.
A new mechanism that stops the progression of Huntington's disease in cells has been identified by scientists at UCL and the University of Cambridge, as part of their research groups at the UK Dementia Research Institute.
› Verified 8 days ago
Entity Name | Advanced Inpatient Medicine Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1871725366 PECOS PAC ID: 6406995778 Enrollment ID: O20091125000458 |
News Archive
A new study has found evidence that marathon running could trigger pulmonary oedema, where fluid builds up in the lungs.
From the World Science Festival in New York, IBM Fellow Dr. Donald M. Eigler was awarded the most prestigious honor in nanoscience, The Kavli Prize, sharing the honor with Nadrian Seeman, a professor at New York University.
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted applications for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of pancreatic and ovarian cancers.
A new mechanism that stops the progression of Huntington's disease in cells has been identified by scientists at UCL and the University of Cambridge, as part of their research groups at the UK Dementia Research Institute.
› Verified 8 days ago
Entity Name | Advanced Inpatient Medicine Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396168589 PECOS PAC ID: 8921230749 Enrollment ID: O20140410000089 |
News Archive
A new study has found evidence that marathon running could trigger pulmonary oedema, where fluid builds up in the lungs.
From the World Science Festival in New York, IBM Fellow Dr. Donald M. Eigler was awarded the most prestigious honor in nanoscience, The Kavli Prize, sharing the honor with Nadrian Seeman, a professor at New York University.
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted applications for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of pancreatic and ovarian cancers.
A new mechanism that stops the progression of Huntington's disease in cells has been identified by scientists at UCL and the University of Cambridge, as part of their research groups at the UK Dementia Research Institute.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Fortunata Verdetti, MD P O Box 1096, Kingston, PA 18704-0096 Ph: (570) 208-5534 | Dr Fortunata Verdetti, MD 2128 Blakeslee Boulevard Dr E, Lehighton, PA 18235-9619 Ph: (610) 402-5369 |
News Archive
A new study has found evidence that marathon running could trigger pulmonary oedema, where fluid builds up in the lungs.
From the World Science Festival in New York, IBM Fellow Dr. Donald M. Eigler was awarded the most prestigious honor in nanoscience, The Kavli Prize, sharing the honor with Nadrian Seeman, a professor at New York University.
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted applications for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of pancreatic and ovarian cancers.
A new mechanism that stops the progression of Huntington's disease in cells has been identified by scientists at UCL and the University of Cambridge, as part of their research groups at the UK Dementia Research Institute.
› Verified 8 days ago
Dr. Mohammad Fawwad Khan, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 211 N 12th St, Lehighton, PA 18235 Phone: 610-377-7174 Fax: 610-377-4785 |